Author
Listed:
- Razi Syed Haq
- Farbod Farmand
- Anthony Rajasingham
(Department of Internal Medicine, Arrowhead Regional Medical Center, USA)
- Sharon Wang
(Department of Infectious Disease, Arrowhead Regional Medical Center, USA)
- Lloyd Muzangwa
- Samuel Beaujean
(St George’s University School of Medicine, West Indies)
Abstract
Coccidioidomycosis is a fungal infection caused by Coccidioides immitis which thrives in dry desert climates such as the southwestern United States. Disseminated coccidioidomycosis is often seen in patients with an underlying immunodeficiency. Historically there have been few reported cases of opportunistic infections in the setting of low CD4+ count and no evidence of HIV infection. Coccidioidomycosis typically presents asymptomatically or as a minor respiratory illness in immunocompetent individuals. We report a case of disseminated coccidioidomycosis in a patient who is otherwise immunocompetent. Patient is a 24-year-old Hispanic male who presented with severe headache, fever, body pain, vomiting, and diarrhea for approximately 14 days. On admission, patient’s CD4+ count was 91 and CSF culture grew Coccidioides immitis, for which patient was started on fluconazole. Patient’s hospital stay was complicated by multiple bouts of altered mental status, fevers, hyponatremia, hydrocephalus, neurogenic bladder, new-onset Mobitz II heart arrhythmia, urinary tract infection, and sepsis. MRI studies revealed abnormal enhancement of leptomeninges, bilateral basal ganglia, thecal sac and cauda equina fibers, signifying disseminated disease. Patient’s serum Coccidioides complement fixation (IgG) titers remained elevated despite aggressive therapy with IV amphotericin B. After a total of six months of hospitalization, including treatment with intrathecal amphotericin B, patient’s last CD4+ count was 549, CSF IgG titers achieved
Suggested Citation
Razi Syed Haq & Farbod Farmand & Anthony Rajasingham & Sharon Wang & Lloyd Muzangwa & Samuel Beaujean, 2019.
"Disseminated Coccidioidomycosis Refractory to Multi-Drug Therapies in an Immunocompetent Patient,"
Open Access Journal of Neurology & Neurosurgery, Juniper Publishers Inc., vol. 11(2), pages 40-43, August.
Handle:
RePEc:adp:joajnn:v:11:y:2019:i:2:p:40-43
DOI: 10.19080/OAJNN.2019.11.555809
Download full text from publisher
More about this item
Keywords
;
;
;
;
;
;
;
;
;
;
;
JEL classification:
- R00 - Urban, Rural, Regional, Real Estate, and Transportation Economics - - General - - - General
- Z0 - Other Special Topics - - General
Statistics
Access and download statistics
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:adp:joajnn:v:11:y:2019:i:2:p:40-43. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Robert Thomas (email available below). General contact details of provider: .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.